Navigation Links
Nipping metastases in the bud
Date:12/7/2011

The proliferation of metastases is often the main cause of complications and death from cancer. For the first time, researchers are looking very closely at the development of these metastases themselves, instead of focusing on the "primary" cancers from which they originated. In doing so, a team from the Swiss Center for Experimental Cancer Research (ISREC), at EPFL, was able to isolate a protein that plays a major role in metastasis development, and showed that the formation of secondary cancers could be prevented by blocking this protein. Their results will be published December 7, 2011, in the advance online edition of the journal Nature and will open the door to new therapeutic options for treating late stage cancers.

A vital protein for metastases

The researchers already knew that cancer cells spread widely throughout the body once a malignant tumor is established. These cells don't always result in a secondary cancer, however. It turns out that all cancer cells aren't created equal: only some of them, known as "cancer stem cells," can initiate metastases. And in order to do this, they must settle into a spot a niche that is conducive for their development.

The ISREC team was able to show that several conditions are necessary for cancer to propagate. "In particular, we were able to isolate a protein, periostin, in the niches where metastases develop," explains Joerg Huelsken, holder of the EPFL Debiopharm Chair in Signal Transduction in Oncogenesis. "Without this protein, the cancer stem cell cannot initiate metastasis; instead, it disappears or remains dormant."

Minimal side effects in mice

Periostin exists naturally as part of the extracellular matrix, and has been shown to play a role in fetal development. In adults, it is only active in specific organs the mammary glands, bones, skin and intestine. This research appears to prove that it plays an essential role in the environment that a cancer
'/>"/>

Contact: Emmanuel Barraud
emmanuel.barraud@epfl.ch
41-21-693-07-52
Ecole Polytechnique Fdrale de Lausanne
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Start spreading the news: NYU scientists find therapeutic target to stop cancer metastases
2. Whole body MRI is highly accurate in the early detection of breast cancer metastases
3. Only 5 percent of cancer research funds are spent on metastases, yet it kills 90 percent of all cancer patients
4. Tumors bring their own support cells when forming metastases
5. Fox Chase researchers uncover new risk factors for brain metastases in breast cancer patients
6. ASTRO publishes palliative radiotherapy for bone metastases guideline
7. UNC physician-scientist receives grant to study breast cancer brain metastases
8. Radionuclide treatment against small tumors and metastases
9. New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
10. Bone-strengthening drug gives pain relief in prostate cancer bone metastases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nipping metastases in the bud
(Date:8/30/2014)... Colorado Springs, CO (PRWEB) August 30, 2014 ... valuable, and increasingly difficult to get. Snoring and sleep apnea ... breathing stops) rob people and their bed partners of the ... Up to 45% of the population snores and 20 million ... these, only 10% have been diagnosed and treated; and of ...
(Date:8/30/2014)... "My wife suffered neck, back and ... said one of two inventors from Bethel, Alaska. "The ... and neck area. She tried other pillows to little ... assisting in comfort and providing extra sleep." , They ... support the head, neck and back comfortably. This enables ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Market ... Industry, 2009-2019 is a professional and in-depth market ... The report firstly reviews the basic information of ... technology. The report then explores global and China’s ... specification, capacity, production value, and market share etc. ...
(Date:8/30/2014)... 30, 2014 Serving contented clients since ... Profit By Outsourcing is now offering discount for ... company gives emphasize on putting forward the best of ... clients. Their dedicated team of professionals and web developers ... can handle even the critical issues of web development ...
(Date:8/30/2014)... 30, 2014 The federal judge ... ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific Corp. ... cases selected for one of the proceeding’s bellwether ... 18, 2014, U.S. District Judge Joseph R. Goodwin ... with Boston Scientific’s contention that a consolidated trial ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3
... firm announced this week that it has developed a ... improve// the efficacy of chemotherapy drugs and reduce drug ... the US subsidiary of Nitto Denko Corporation, says its ... biocompatible polymer material which can be loaded with therapeutic ...
... study appearing in the Journal of Clinical Oncology reveals ... the lives of patients// with recurrent prostate cancer. ... targeted drugs that scientists at Cedars-Sinai Medical Center in ... in some prostate cancer patients with no previous chemotherapy ...
... of the Medgadget "Most Sci-Fi Sounding Company Name" Award, ... Andara OFS nerve growth stimulation system. ,According ... battery-powered device about the size of a cardiac pacemaker ... attached to the vertebrae at a distance of two ...
... have cautioned about the risk of mercury in canned albacore ... regarding the consumption of tuna in women and children. This ... 8 out of 60 cans of albacore tuna tested contained ... this guideline, four servings of canned albacore tuna per week ...
... A research team has identified certain chemical marks that help ... cells in liposuctioned fat, are best at regenerating// tissue. ... body fat to improve their looks. But unwanted fat also ... heal injuries in the body. ,Uncovering the nature ...
... Medicine have succeeded in producing neurons in vitro ... This is the first time// such an advanced ... from human skin, according to lead researcher Professor ... revolutionary advances in the treatment of neurodegenerative illnesses ...
Cached Medicine News:Health News:New Cost-cutting Cancer Drug Delivery System 2Health News:New Cost-cutting Cancer Drug Delivery System 3Health News:Stem Cells in Liposuctioned Fat can Heal Injuries 2Health News:Scientists Produce Neurons from Human Skin 2
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)...   Vittamed Corporation , a neurodiagnostics medical device company ... T. (Teo) Forcht Dagi , MD, DmedSc, MPH, MBA, ... " Teo Forcht Dagi is an ... and venture capital," said Remis Bistras , President and ... clinical, strategic, and entrepreneurial expertise to our Board." ...
(Date:8/29/2014)... 2014 Research and Markets has ... Drugs Market 2014-2018" report to their offering. ... condition that results in demyelination, axonal transection, and neurodegeneration. ... response by the immune system, which targets neurons within ... debilitating disease in which the damage of the myelin ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... ANNAPOLIS, Md., Oct. 13, 2011 PharmAthene, Inc. (NYSE Amex: ... its legal brief in response to SIGA Technologies, motion for ... Court of Chancery had issued a ruling in its litigation ... over 10 years from all sales of ST-246 and related ...
... 13, 2011 A Medco Health Solutions, Inc. (NYSE: ... 38 percent of patients prescribed Plavix® (clopidogrel)—an anti-platelet drug ... also using another drug that would impede its effectiveness. ... analysis also showed that primary care physicians seem willing ...
Cached Medicine Technology:PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 2PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4